Pradaxa Settlement Announced to be a Potential $650 Million Deal
Boehringer Ingelheim, the manufacturer of the blood thinning drug Pradaxa, announced a $650 million settlement deal today to settle around 4,000 state and federal lawsuits.
Pradaxa is a widely-used blood thinner, but it has been alleged to cause fatal bleeding, digestive track ulcers, and brain hemorrhaging. Patients who filed suits over Pradaxa alleged it caused massive bleeding, hemorrhaging, atrial fibrillation, and even death.
The law firm of Zoll, Kranz & Borgess, LLC has substantial experience in pharmaceutical, medical device and defective product litigation. We have been investigating the Pradaxa mass tort and are open to discuss your potential claim. Contact us immediately toll-free at (888)841-9623 if you or a loved has been injured by Pradaxa. You can also fill out the form to the right and we will be in touch with you right away.